You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68Ga-GRP PET/CT

Showing 51 - 75 of 9,675
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumors Trial in Marseille ([68Ga]-DOTANOC PET/CT)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumors
  • [68Ga]-DOTANOC PET/CT
  • Marseille, France
    AP-HM
Oct 12, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

Terminated
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Breast Cancer Trial in Beijing (Drug: 68Ga-P16-093)

Recruiting
  • Breast Cancer
  • Drug: 68Ga-P16-093
  • Beijing, China
    Peking Union Medical College Hospital
Nov 14, 2022

Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

Active, not recruiting
Has Results
  • Prostate Cancer
  • High Risk
  • Houston, Texas
    Houston Methodist
Dec 8, 2022

Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)

Recruiting
  • Tumor, Solid
  • Positron-Emission Tomography
  • 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Sep 16, 2022

Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)

Recruiting
  • Prostate Cancer Metastatic
  • Peking, China
    Peking Union Medical College Hospital
Nov 25, 2022

Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)

Recruiting
  • Breast Neoplasms
  • +3 more
  • 68Ga-FAPI-46 PET/CT
  • Baku, Azerbaijan
    National Centre of Oncology
Jun 21, 2022

Oral Carcinoma Trial in Beijing (68Ga-FAPI-04)

Recruiting
  • Oral Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Oct 26, 2022

Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

Recruiting
  • Breast Cancer
  • Sydney, New South Wales, Australia
    St Vincent's Hospital
May 22, 2023

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Tumor Trial in Fuzhou (68Ga-FAP-RGD)

Recruiting
  • Tumor
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 23, 2022

Tumor, Positron-Emission Tomography Trial in Fuzhou (68Ga-FAP-CHX)

Recruiting
  • Tumor
  • Positron-Emission Tomography
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 17, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

Terminated
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022

Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)

Recruiting
  • Breast Cancer
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2022

Infective Endocarditis Trial in Bordeaux (68Ga-citrate PET/CT)

Not yet recruiting
  • Infective Endocarditis
  • 68Ga-citrate PET/CT
  • Bordeaux, France
    CHU de Bordeaux
Jul 6, 2022

Post-Acute COVID-19, Post-Acute COVID-19 Infection, Post-Acute COVID-19 Syndrome Trial in Groningen

Recruiting
  • Post-Acute COVID-19
  • +3 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Aug 3, 2023

    Glioma Trial in Beijing (68Ga-P16-093)

    Recruiting
    • Glioma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Oct 4, 2022

    Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

    Not yet recruiting
    • Solid Tumor
    • Positron-Emission Tomography(PET)
    • [68Ga]Ga-NOTA-SNA002
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Aug 3, 2022

    Lung Tumors Trial in Beijing (68Ga-FAPI-RGD, 18F-FDG, 68Ga-FAPI)

    Recruiting
    • Lung Neoplasms
    • Beijing, China
      Peking Union Medical College Hospital
    Sep 13, 2022

    68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

    Not yet recruiting
    • 68Ga-FAPI
    • +3 more
    • 68Ga-FAPI
    • Shanghai, Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    May 3, 2023

    Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission

    Available
    • Prostate Cancer
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Sep 27, 2022

    Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)

    Recruiting
    • Insulinoma
    • Fuzhou, Fujian, China
      Department of Nuclear Medicine, First Affiliated Hospital of Fuj
    Jul 29, 2022

    Acute Cellular Graft Rejection, Cardiac Sarcoidosis, Myocarditis Due to Drug Trial in Lausanne ([68Ga]Ga-PentixaFor PET/CT)

    Not yet recruiting
    • Acute Cellular Graft Rejection
    • +2 more
    • [68Ga]Ga-PentixaFor PET/CT
    • Lausanne, Vaud, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Aug 11, 2022

    Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

    Recruiting
    • Prostate Cancer
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 1, 2022